Sponsored by:

Nuclear Medicine: Page 391

NAS Q3 continues sales downturn, expands brachytherapy outreach
By AuntMinnie.com staff writers
Radiopharmaceutical developer North American Scientific (NAS) reported third-quarter net sales of $3 million, down 76% from the $5.3 million booked in the third quarter of 2002.
August 27, 2003
Novoste suspends Mobile trial, restructures company
By AuntMinnie.com staff writers
Vascular brachytherapy firm Novoste has suspended enrollment in its Mobile trial, a clinical trial initiated in 2001 to test the efficacy of vascular brachytherapy for the treatment of failed stents in the peripheral arteries.
August 26, 2003
Molecular Imaging notches 2003 revenue uptick
By AuntMinnie.com staff writers
Molecular Imaging reported unaudited fiscal fourth-quarter revenues of $5.7 million, up 20% from the $4.8 million posted in the fourth quarter last year.
August 25, 2003
International Isotopes to launch lutetium-177
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes is planning to launch a lutetium-177 isotope.
August 25, 2003
FDG-PET, scintigraphy offer a break in fever of unknown origin
By Shalmali Pal
Before they became the object of media obsession, chances are the early symptoms of SARS, West Nile virus, and inhalation anthrax could be pegged as fevers of unknown origin. Diagnosing FUO can be a long and involved process -- one that molecular imaging specialists from Denmark, Germany, and the Netherlands are looking to simplify.
August 21, 2003
2003 08 15 14 22 42 706
PET pinpoints foci of elusive fevers
By Jonathan S. Batchelor
Investigators from Germany and the Netherlands presented the results of their work on the use of FDG-PET for fever of unknown origin diagnosis at the recent Society of Nuclear Medicine conference in New Orleans.
August 17, 2003
Cytogen revenues sag
By AuntMinnie.com staff writers
Biopharmaceutical firm Cytogen reported second-quarter revenues of $2.3 million, down 26.5% compared with the $3.2 million posted in the second quarter of 2002.
August 14, 2003
TNT gets clearance in China
By AuntMinnie.com staff writers
Iodine-131-radiolabeled tumor necrosis therapy (TNT) has received marketing approval for lung cancer treatment in the People’s Republic of China, according to biopharmaceutical developer Peregrine Pharmaceuticals and its Chinese partner, MediPharm Biotech.
August 12, 2003
Bracco adds Christus Health
By AuntMinnie.com staff writers
Bracco Diagnostics is providing health system Christus Health with access to its radiopharmaceutical and diagnostic imaging agents, thanks to a recent agreement between Christus and group purchasing organization Broadlane.
August 12, 2003
MDS Nordion inks licensing deal
By AuntMinnie.com staff writers
Canadian medical isotope supplier MDS Nordion has signed a licensing agreement with NTP Radioisotopes, a subsidiary of South African Nuclear Energy Corporation.
August 11, 2003
AIDS specialist advocates tailored imaging in HIV-positive patients
Choosing the right imaging tool at the right time is vital for evaluating patients with HIV disease, according to Dr. Gabriele Arendt from the University of Dusseldorf in Germany. MRI, for instance, is best suited for the late stages of AIDS, while PET and spectroscopy can yield information before clinical signs appear.
August 6, 2003
2003 08 06 12 19 37 706
Digirad debuts single-head gamma camera
By AuntMinnie.com staff writers
Solid-state gamma camera developer Digirad has released Cardius-1, a single-head gamma camera dedicated to cardiac imaging.
August 3, 2003
Previous Page
Page 391 of 440
Next Page